In the present study, we found significant downregulation of ACADL expression by comparing the expression profiles of NSCLC and adjacent tumors, and demonstrated that overexpression of ACADL can inhibit tumor progression in vitro and transplanted tumor models. Here, ACADL is linked to non-small cell lung carcinoma.